For the first time, researchers have transformed human stem cells into mature insulin-producing cells. The breakthrough could lead us a step closer to developing a cure for Type 1 diabetes.
A small clinical trial has shown that when multiple sclerosis patients received a stem cell transplant alongside their chemotherapy, the majority demonstrated improvements in their quality of life.
A Phase 1 clinical trial has investigated the effect of umbilical cord-derived MSCs on the immune systems of Lupus patients. Although the study was small, positive results were observed 24 weeks post-treatment.
A new study suggests that umbilical cord tissue could one day be used to treat chronic, non-healing diabetic foot ulcers. EpiCord, a thick membrane product produced from umbilical cords, has been studied and tested as a form of wound dressing and healing for the ulcers.
Researchers at the Stowers Institute of Medical Research have found another way to expand/multiply blood-forming, adult stem cells from umbilical cord blood. The discovery increases the potential of a single stem cell sample in treating more conditions.
